Ignite Creation Date:
2024-05-06 @ 3:28 PM
Last Modification Date:
2024-10-26 @ 1:50 PM
Study NCT ID:
NCT04649021
Status:
COMPLETED
Last Update Posted:
2022-05-10
First Post:
2020-11-17
Brief Title:
Safety and Immunogenicity of SARS-CoV-2 mRNA Vaccine BNT162b2 in Chinese Healthy Population
Sponsor:
BioNTech SE
Organization:
BioNTech SE